Drug Approval | July 24, 2022
SMS Pharmaceuticals receives approval for Ibuprofen by EDQM
With this, the company can start selling Ibuprofen in the European markets.
With this, the company can start selling Ibuprofen in the European markets.
Company raises the annual revenue guidance from mid-teens to high teens
The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).
Subscribe To Our Newsletter & Stay Updated
